2022/23 community pharmacy contractual framework (CPCF) national clinical audit: Valproate audit

Document first published:
Page updated:
Topic:
,
Publication type:

This guidance document provides information on the 2022/23 Community pharmacy contractual framework national audit, which is focused on reducing the potential for harm from valproate prescribing in patients of childbearing age who are biologically able to be pregnant.

Link

2022/23 community pharmacy contractual framework national clinical audit: Valproate audit

2022/23 community pharmacy contractual framework national clinical audit: Valproate audit

NHS England is not responsible for content on external websites.

Summary

Accessible version.

Document

2022/23 community pharmacy contractual framework national clinical audit: Valproate audit

2022/23 community pharmacy contractual framework national clinical audit: Valproate audit

  • PDF
  • 366 KB
  • 12 pages

Summary

PDF version.

Document

Appendix A: Audit data collection sheet

Appendix A: Audit data collection sheet

  • Microsoft Word
  • 23 KB
  • 3 pages

Document

Appendix B: Pharmacy contractor review of the audit results

Appendix B: Pharmacy contractor review of the audit results

  • Microsoft Word
  • 17 KB
  • 1 pages

Link

Community pharmacy preventing harm from valproate – Pharmacy Quality Scheme audit report 2019-20

Community pharmacy preventing harm from valproate – Pharmacy Quality Scheme audit report 2019-20

NHS England is not responsible for content on external websites.

Summary

This report details the results and findings of the valproate audit and makes recommendations on further actions to reduce preventable harm.